Johnson & Johnson Boosts Planned US Investment to More Than $55 Billion

MT Newswires03-21

JNJ -Shutterstock

Johnson & Johnson (JNJ) said Friday that it plans to increase its US investment to more than $55 billion over the next four years to boost its manufacturing and research capabilities.

The healthcare products conglomerate said the investment represents a 25% increase compared with the previous four years and covers manufacturing, research and development, and technology.

Johnson & Johnson aims to build three new manufacturing plants and expand several sites related to its innovative medicine and MedTech businesses. The plan includes R&D investments to develop treatments in areas such as oncology, neuroscience, immunology, cardiovascular disease, and robotic surgery.

The move comes as companies, including in the pharmaceutical industry, face uncertainty amid US tariff plans. Last month, Eli Lilly (LLY) announced a plan to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the US.

In a separate statement on Friday, Johnson & Johnson said it will break ground on its new biologics manufacturing facility in Wilson, North Carolina. The plant will boost the company's capacity to deliver medicines treating cancer, immune-mediated and neurological diseases.

"Our increased US investment begins with the ground-breaking of a high-tech facility in North Carolina that will not only add US-based jobs but manufacture cutting-edge medicines to treat patients in America and around the world," Johnson & Johnson Chief Executive Joaquin Duato said in a statement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2521239254?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-21 23:04","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2521239254","market":"us","top_or_hot":-1,"title":"Johnson & Johnson Boosts Planned US Investment to More Than $55 Billion","media":"MT Newswires","content":"<html><body><figure>\n<img src=\"https://s.yimg.com/uu/api/res/1.2/mUQ5JkdQAxJfgd7GbzrfrQ--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/mt_newswires_premium_news_706/3d4757f9301cb315f512556676331838\"/>\n<figcaption>\n  JNJ -Shutterstock\n </figcaption>\n</figure> Johnson &amp; Johnson (JNJ) said Friday that it plans to increase its US investment to more than $55 billion over the next four years to boost its manufacturing and research capabilities.\n<br/>\n<br/> The healthcare products conglomerate said the investment represents a 25% increase compared with the previous four years and covers manufacturing, research and development, and technology.\n<br/>\n<br/> Johnson &amp; Johnson aims to build three new manufacturing plants and expand several sites related to its innovative medicine and MedTech businesses. The plan includes R&amp;D investments to develop treatments in areas such as oncology, neuroscience, immunology, cardiovascular disease, and robotic surgery.\n<br/>\n<br/> The move comes as companies, including in the pharmaceutical industry, face uncertainty amid US tariff plans. Last month, Eli Lilly (LLY) announced a plan to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the US.\n<br/>\n<br/> In a separate statement on Friday, Johnson &amp; Johnson said it will break ground on its new biologics manufacturing facility in Wilson, North Carolina. The plant will boost the company's capacity to deliver medicines treating cancer, immune-mediated and neurological diseases.\n<br/>\n<br/> \"Our increased US investment begins with the ground-breaking of a high-tech facility in North Carolina that will not only add US-based jobs but manufacture cutting-edge medicines to treat patients in America and around the world,\" Johnson &amp; Johnson Chief Executive Joaquin Duato said in a statement.\n<br/>\n<br/>\n<br/>\n<br/>\n<br/>\n<br/>\n<br/>\n<br/>\n<br/>\n<br/></body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Johnson & Johnson Boosts Planned US Investment to More Than $55 Billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJohnson & Johnson Boosts Planned US Investment to More Than $55 Billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-03-21 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/johnson-johnson-boosts-planned-us-150446880.html><strong>MT Newswires</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>JNJ -Shutterstock\n \n Johnson & Johnson (JNJ) said Friday that it plans to increase its US investment to more than $55 billion over the next four years to boost its manufacturing and research ...</p>\n\n<a href=\"https://finance.yahoo.com/news/johnson-johnson-boosts-planned-us-150446880.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://finance.yahoo.com/news/johnson-johnson-boosts-planned-us-150446880.html","article_id":"2521239254","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2521239254","pubTimestamp":1742569486,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Johnson & Johnson  said Friday that it plans to increase its US investment to more than $55 billion over the next four years to boost its manufacturing and research capabilities.The healthcare products conglomerate said the investment represents a 25% increase compared with the previous four years and covers manufacturing, research and development, and technology.Johnson & Johnson aims to build three new manufacturing plants and expand several sites related to its innovative medicine and MedTech businesses. The plan includes R&D investments to develop treatments in areas such as oncology, neuroscience, immunology, cardiovascular disease, and robotic surgery.The move comes as companies, including in the pharmaceutical industry, face uncertainty amid US tariff plans. Last month, Eli Lilly  announced a plan to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the US.\"Our increased US investment begins with the ground-breaking of a high-tech facility in No","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"强生公司将美国计划投资提高至550亿美元以上","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JNJ":1,"LLY":1},"content_text":"JNJ -Shutterstock\n \n Johnson & Johnson (JNJ) said Friday that it plans to increase its US investment to more than $55 billion over the next four years to boost its manufacturing and research capabilities.\n\n The healthcare products conglomerate said the investment represents a 25% increase compared with the previous four years and covers manufacturing, research and development, and technology.\n\n Johnson & Johnson aims to build three new manufacturing plants and expand several sites related to its innovative medicine and MedTech businesses. The plan includes R&D investments to develop treatments in areas such as oncology, neuroscience, immunology, cardiovascular disease, and robotic surgery.\n\n The move comes as companies, including in the pharmaceutical industry, face uncertainty amid US tariff plans. Last month, Eli Lilly (LLY) announced a plan to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the US.\n\n In a separate statement on Friday, Johnson & Johnson said it will break ground on its new biologics manufacturing facility in Wilson, North Carolina. The plant will boost the company's capacity to deliver medicines treating cancer, immune-mediated and neurological diseases.\n\n \"Our increased US investment begins with the ground-breaking of a high-tech facility in North Carolina that will not only add US-based jobs but manufacture cutting-edge medicines to treat patients in America and around the world,\" Johnson & Johnson Chief Executive Joaquin Duato said in a statement.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2521239254"}